Case Report: Clinicopathological features and outcomes of superficial cervicovaginal myofibroblastoma: analysis of two cases and a review of the literature - Report - MDSpire

Case Report: Clinicopathological features and outcomes of superficial cervicovaginal myofibroblastoma: analysis of two cases and a review of the literature

  • By

  • Xiaoli Cai

  • Yanli Liu

  • Yunfeng Niu

  • Xiaodan Shen

  • Qian Zhang

  • Lei Liang

  • Shuang Liu

  • May 13, 2026

  • 0 min

Share

Clinical Report: Insights and Outcomes of Superficial Cervicovaginal Myofibroblastoma

Overview

This report presents two cases of superficial cervicovaginal myofibroblastoma (SCVM) and reviews 78 cases from literature. SCVM is a rare benign tumor predominantly affecting women aged 20-60, with a favorable prognosis following surgical excision.

Background

Superficial cervicovaginal myofibroblastoma (SCVM) is a rare benign mesenchymal tumor that poses diagnostic challenges due to its overlapping features with other soft tissue tumors. It primarily affects women of reproductive age and can present with symptoms such as vaginal bleeding or be asymptomatic. Accurate diagnosis is crucial to avoid mismanagement and ensure appropriate treatment.

Data Highlights

No numerical data or trial data were provided in the article.

Key Findings

  • SCVM is predominantly found in women aged 20-60 years.
  • Clinical manifestations include irregular vaginal bleeding and incidental findings during examinations.
  • Histopathological diagnosis relies on the evaluation of morphology and immunohistochemical profiles.
  • Surgical excision is the primary treatment, with a favorable prognosis and extremely low recurrence rates.
  • SCVM exhibits hormone-related characteristics, indicating a potential sensitivity to estrogen.

Clinical Implications

Healthcare professionals should maintain a high index of suspicion for SCVM in women presenting with vaginal masses or bleeding. Accurate diagnosis through histopathological and immunohistochemical evaluation is essential to differentiate SCVM from other mesenchymal tumors and to guide appropriate management.

Conclusion

Strengthen the conclusion with a call to action for improved awareness and practices.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. Author(s)/Org, Source, Year -- Title
  3. Author(s)/Org, Source, Year -- Title
  4. Author(s)/Org, Source, Year -- Title
  5. WHO Classification of Tumours, 5th edition: Corrigenda
  6. Cervical superficial myofibroblastoma: Case report and review of the literature - PMC
  7. Superficial myofibroblastoma of the lower female genital tract: A clinicopathological analysis of 15 cases - ScienceDirect
  8. WHO Classification of Tumours, 5th edition
  9. Cervical superficial myofibroblastoma: Case report and review of the literature - PMC
  10. Superficial myofibroblastoma of the lower female genital tract: A clinicopathological analysis of 15 cases - ScienceDirect

Original Source(s)

Related Content